AAAAAA
Results: 226-250/568
Authors:
MICHICH E
Citation: E. Michich, UCHIDA,ATSUSHI - IN-MEMORIAM, Cancer immunology and immunotherapy, 43(1), 1996, pp. 63-63
Authors:
VOOIJS WC
POST J
WIJDENES J
SCHUURMAN HJ
BOLOGNESI A
POLITO L
STIRPE F
BAST EJEG
DEGAST GC
Citation: Wc. Vooijs et al., EFFICACY AND TOXICITY OF PLASMA-CELL-REACTIVE MONOCLONAL-ANTIBODIES B-B2 AND B-B4 AND THEIR IMMUNOTOXINS, Cancer immunology and immunotherapy, 42(6), 1996, pp. 319-328
Authors:
GELDHOF AB
VANDENDRIESSCHE T
OPDENAKKER G
DEBAETSELIER P
Citation: Ab. Geldhof et al., INTRODUCTION OF THE INTERFERON-GAMMA GENE INTO MOUSE T-LYMPHOMA-CELLSWITH LOW MHC CLASS-I-EXPRESSION RESULTS IN SELECTIVE INDUCTION OF H-2D(K) AND CONCOMITANT ENHANCED METASTASIS, Cancer immunology and immunotherapy, 42(6), 1996, pp. 329-338
Authors:
LORESVAZQUEZ B
PACHECOCARRACEDO M
OLIVERMORALES J
PARADAGONZALEZ P
GAMBONDEZA F
Citation: B. Loresvazquez et al., LYMPHOCYTE SUBPOPULATIONS OF REGIONAL LYMPH-NODES IN HUMAN COLON AND GASTRIC ADENOCARCINOMAS, Cancer immunology and immunotherapy, 42(6), 1996, pp. 339-342
Authors:
SOMASUNDARAM C
ARCH R
MATZKU S
ZOLLER M
Citation: C. Somasundaram et al., DEVELOPMENT OF A BISPECIFIC F(AB')2 CONJUGATE AGAINST THE COMPLEMENT RECEPTOR CR3 OF MACROPHAGES AND A VARIANT CD44 ANTIGEN OF RAT PANCREATIC ADENOCARCINOMA FOR REDIRECTING MACROPHAGE-MEDIATED TUMOR-CYTOTOXICITY, Cancer immunology and immunotherapy, 42(6), 1996, pp. 343-350
Authors:
MULDER WMC
STUKART MJ
DEWINDT E
WAGSTAFF J
SCHEPER RJ
BLOEMENA E
Citation: Wmc. Mulder et al., MUCIN-1-RELATED T-CELL INFILTRATION IN COLORECTAL-CARCINOMA, Cancer immunology and immunotherapy, 42(6), 1996, pp. 351-356
Authors:
RECHT LD
RASO V
DAVIS R
SALMONSEN R
Citation: Ld. Recht et al., IMMUNOTOXIN SENSITIVITY OF CHINESE-HAMSTER OVARY CELLS EXPRESSING HUMAN TRANSFERRIN RECEPTORS WITH DIFFERING INTERNALIZATION RATES, Cancer immunology and immunotherapy, 42(6), 1996, pp. 357-361
Authors:
WEI CW
STOROZYNSKY E
MCADAM AJ
YEH KY
TILTON BR
WILLIS RA
BARTH RK
LOONEY RJ
LORD EM
FRELINGER JG
Citation: Cw. Wei et al., EXPRESSION OF HUMAN PROSTATE-SPECIFIC ANTIGEN (PSA) IN A MOUSE-TUMOR CELL-LINE REDUCES TUMORIGENICITY AND ELICITS PSA-SPECIFIC CYTOTOXIC T-LYMPHOCYTES, Cancer immunology and immunotherapy, 42(6), 1996, pp. 362-368
Authors:
JACOBS N
GREIMERS R
MAZZONI A
TREBAK M
SCHAAFLAFONTAINE N
BONIVER J
MOUTSCHEN RP
Citation: N. Jacobs et al., FURTHER CHARACTERIZATION OF CYTOTOXIC T-CELLS GENERATED BY SHORT-TERMCULTURE OF HUMAN PERIPHERAL-BLOOD LYMPHOCYTES WITH INTERLEUKIN-2 AND ANTI-CD3 MAB, Cancer immunology and immunotherapy, 42(6), 1996, pp. 369-375
Authors:
BERD D
MASTRANGELO MJ
LATTIME E
SATO T
MAGUIRE HC
Citation: D. Berd et al., MELANOMA AND VITILIGO - IMMUNOLOGYS GRECIAN URN, Cancer immunology and immunotherapy, 42(5), 1996, pp. 263-267
Authors:
KONISHI F
MITSUYAMA M
OKUDA M
TANAKA K
HASEGAWA T
NOMOTO K
Citation: F. Konishi et al., PROTECTIVE EFFECT OF AN ACIDIC GLYCOPROTEIN OBTAINED FROM CULTURE OF CHLORELLA-VULGARIS AGAINST MYELOSUPPRESSION BY 5-FLUOROURACIL, Cancer immunology and immunotherapy, 42(5), 1996, pp. 268-274
Authors:
ASAI K
KATO H
KIMURA S
MUKAI S
KAWAHITO Y
SANO H
KONDO M
AKAOGI K
HIROSE K
Citation: K. Asai et al., INDUCTION OF GENE-EXPRESSION FOR NITRIC-OXIDE SYNTHASE BY IMMUNOMODULATING DRUGS IN THE RAW264.7 MURINE MACROPHAGE CELL-LINE, Cancer immunology and immunotherapy, 42(5), 1996, pp. 275-279
Authors:
FUJIMOTO T
ODONNELL MA
SZILVASI A
YANG H
DUDA RB
Citation: T. Fujimoto et al., BACILLUS-CALMETTE-GUERIN PLUS INTERLEUKIN-2 AND OR GRANULOCYTE/MACROPHAGE-COLONY-STIMULATING FACTOR ENHANCES IMMUNOCOMPETENT CELL PRODUCTION OF INTERFERON-GAMMA, WHICH INHIBITS B16F10 MELANOMA CELL-GROWTH IN-VITRO/, Cancer immunology and immunotherapy, 42(5), 1996, pp. 280-284
Authors:
WATANABE T
Citation: T. Watanabe, SUPPRESSIVE EFFECTS OF LACTOBACILLUS-CASEI CELLS, A BACTERIAL IMMUNOSTIMULANT, ON THE INCIDENCE OF SPONTANEOUS THYMIC LYMPHOMA IN AKR MICE, Cancer immunology and immunotherapy, 42(5), 1996, pp. 285-290
Authors:
VERVOORDELDONK SF
HEIKENS J
GOEDEMANS WT
MERLE PA
VONDEMBORNE AEGK
VANROYEN EA
SLAPERCORTENBACH ICM
VANOERS RHJ
Citation: Sf. Vervoordeldonk et al., TC-99M-CD19 MONOCLONAL-ANTIBODY IS NOT USEFUL FOR IMAGING OF B-CELL NON-HODGKINS-LYMPHOMA, Cancer immunology and immunotherapy, 42(5), 1996, pp. 291-296
Authors:
MERIMSKY O
BAHARAV E
SHOENFELD Y
CHAITCHIK S
TSIGELMAN R
COHENALORO D
FISHMAN P
Citation: O. Merimsky et al., ANTI-TYROSINASE ANTIBODIES IN MALIGNANT-MELANOMA, Cancer immunology and immunotherapy, 42(5), 1996, pp. 297-302
Authors:
REDDISH MA
MACLEAN GD
POPPEMA S
BERG A
LONGENECKER BM
Citation: Ma. Reddish et al., PRE-IMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AND CD69(-TN-KLH CANCER VACCINE IN ACTIVE SPECIFIC IMMUNOTHERAPY() LYMPHOCYTES CORRELATE WITH EFFECTS OF THERATOPE(R) SIALYL), Cancer immunology and immunotherapy, 42(5), 1996, pp. 303-309
Authors:
KOENEN HJPM
SMIT MJ
SIMMELINK MMJA
SCHUURMAN B
BEELEN RHJ
MEIJER S
Citation: Hjpm. Koenen et al., EFFECT OF INTRAPERITONEAL ADMINISTRATION OF GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR IN RATS ON OMENTAL MILKY-SPOT COMPOSITION AND TUMORICIDAL ACTIVITY IN-VIVO AND IN-VITRO/, Cancer immunology and immunotherapy, 42(5), 1996, pp. 310-316
Authors:
BONMASSAR E
Citation: E. Bonmassar, IN-MEMORIAM DONOFRIO,CHIARA - OBITUARY, Cancer immunology and immunotherapy, 42(5), 1996, pp. 317-317
Authors:
KIRKIN AF
STRATEN PT
ZEUTHEN J
Citation: Af. Kirkin et al., DIFFERENTIAL MODULATION BY INTERFERON-GAMMA OF THE SENSITIVITY OF HUMAN-MELANOMA CELLS TO CYTOLYTIC T-CELL CLONES THAT RECOGNIZE DIFFERENTIATION OR PROGRESSION ANTIGENS, Cancer immunology and immunotherapy, 42(4), 1996, pp. 203-212
Authors:
PRECHEL MM
LOZANO Y
WRIGHT MA
IHM J
YOUNG MRI
Citation: Mm. Prechel et al., IMMUNE MODULATION BY INTERLEUKIN-12 IN TUMOR-BEARING MICE RECEIVING VITAMIN-D-3 TREATMENTS TO BLOCK INDUCTION OF IMMUNOSUPPRESSIVE GRANULOCYTE MACROPHAGE PROGENITOR CELLS/, Cancer immunology and immunotherapy, 42(4), 1996, pp. 213-220
SPECIFIC ANTI-EL4-LYMPHOMA IMMUNITY IN MICE CURED 2 YEARS EARLIER WITH DOXORUBICIN AND INTERLEUKIN-2
Authors:
EHRKE MJ
VERSTOVSEK S
ZALESKIS G
HO RLX
UJHAZY P
MACCUBBIN DL
MIHICH E
Citation: Mj. Ehrke et al., SPECIFIC ANTI-EL4-LYMPHOMA IMMUNITY IN MICE CURED 2 YEARS EARLIER WITH DOXORUBICIN AND INTERLEUKIN-2, Cancer immunology and immunotherapy, 42(4), 1996, pp. 221-230
Authors:
HIGASHIYAMA A
WATANABE H
OKUMURA K
YAGITA H
Citation: A. Higashiyama et al., INVOLVEMENT OF TUMOR-NECROSIS-FACTOR-ALPHA AND VERY LATE ACTIVATION ANTIGEN-4 VASCULAR CELL-ADHESION MOLECULE-1 INTERACTION IN SURGICAL-STRESS-ENHANCED EXPERIMENTAL METASTASIS, Cancer immunology and immunotherapy, 42(4), 1996, pp. 231-236
Authors:
ARCA MJ
KRAUSS JC
STROME SE
CAMERON MJ
CHANG AE
Citation: Mj. Arca et al., DIVERSE MANIFESTATIONS OF TUMORIGENICITY AND IMMUNOGENICITY DISPLAYEDBY THE POORLY IMMUNOGENIC B16-BL6 MELANOMA TRANSDUCED WITH CYTOKINE GENES, Cancer immunology and immunotherapy, 42(4), 1996, pp. 237-245
Authors:
MCINTYRE CA
REES RC
PLATTS KE
COOKE CJ
SMITH MO
MULCAHY KA
MURRAY AK
Citation: Ca. Mcintyre et al., IDENTIFICATION OF PEPTIDE EPITOPES OF MAGE-1, MAGE-2, MAGE-3 THAT DEMONSTRATE HLA-A3-SPECIFIC BINDING, Cancer immunology and immunotherapy, 42(4), 1996, pp. 246-250